Despite their opportunities and the potential for groundbreaking discoveries, biotech companies also face significant challenges just getting off the ground.

Pilgrim, which makes a hemostatic dressing and other biotech products aimed at military and commercial use, raised $4.3 ...

Third Rock Ventures delivered the best returns among 22 prominent biotech venture capital firms analyzed by STAT.

Insider asked 12 top VCs to name biotech startups poised to take off in the next 12 months. Here are the 24 startups they named and what each biotech is working on. They are revolutionizing ...

Venture firm Eclipse, which specializes in industrial startups, was one of the first to take a chance on the startup, leading its $18 million Series A in 2019, with participation from 8VC, led by ...

"We believe Gameto has the potential to drive the biggest transformation in women's health since the birth control pill," the ...

Biotech venture capital funding remains robust, but a troubling trendline in venture formation suggests a change in new startup activity ...

CircNova, a Michigan-based biotech startup, has completed a $3.3 million seed round to advance its technology, which uses artificial intelligence (AI) to target “circular RNA.” Crystal Brown ...

The median step up in biotech valuations from seed to Series A is now 2x, higher than in all later rounds. As a result, biotech startups will continue to attract more investment at earlier stages.

To get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today.

Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software. The project, called OpenFold, brings together Cyrus Biotechnology ...

Celularity Inc., a biotechnology startup backed with more than $300 million in venture capital, is widening its battle against the coronavirus pandemic through a new agreement with United ...